Nucleus Software Exports Limited has informed the Exchange about the Board of Directors, at its meeting held on March 25, 2026, has approved the request of Dr. Ritika Dusad, Executive Director, for an extension of her sabbatical leave for a further period of up to one year i.e. until March 30, 2027
NUCLEUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The Board of Nucleus Software Exports has approved an extension of the sabbatical leave for Dr. Ritika Dusad, Executive Director, for up to one year until March 30, 2027. Dr. Dusad, who holds a Ph.D. in Physics and has over three years of experience with the company, is currently pursuing a management development program and exploring new business areas during her sabbatical. She will resume her executive responsibilities once the sabbatical period ends. The intimation was made under SEBI Listing Regulations, with the Board approval granted at its meeting on March 25, 2026.
This is a neutral development for shareholders. Dr. Dusad is not resigning but continuing an already-existing sabbatical, suggesting the company has continuity plans in place. No immediate change in leadership or business direction is expected.